More gastrointestinal and nervous symptom adverse events (AEs) are linked to apremilast than deucravacitinib, which is associated with more cutaneous AEs, according to a retrospective comparison using ...
Hosted on MSN
FDA launches new adverse event look-up tool
WASHINGTON - The Food and Drug Administration has launched what it is describing as a "unified dashboard" for identifying and monitoring unexpected side effects or injuries caused by approved medical ...
The FDA has launched a new adverse event reporting system that will consolidate several systems it has for reporting different types of adverse events, the agency announced Wednesday. The new system, ...
The FDA has launched a new adverse event reporting system that will consolidate several systems it has for reporting different types of adverse events, the agency announced Wednesday. The new system, ...
The US Food and Drug Administration (FDA) announced it is unifying its various adverse reporting systems into a single system called the Adverse Event Monitoring System (AEMS). The agency said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results